Europe Stroke Management Market By Type (Diagnostics - Computed Tomography Scan, Magnetic Resonance Imaging, Echocardiography, Carotid Ultrasound, Cerebral Angiography, Electrocardiography; Therapeutics - Tissue Plasminogen Activator, Anticoagulant, Antiplatelet), Application (Ischemic, Haemorrhagic)

The Europe Stroke Management Market would witness market growth of 6.7% CAGR during the forecast period (2018 – 2024). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advanced devices and drugs would limit the market growth.

Click Here For Free Insights:

Based on Application, the market is segmented into Ischemic Stroke and Hemorrhagic Stroke. Based on Type, the market is segmented into Diagnostics and Therapeutics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, B. Braun Melsungen Ag, Boston Scientific Corporation, Cardinal Health, Inc., Ge Healthcare, Glaxosmithkline Plc, Medtronic Plc., Siemens Aktiengesellschaft, Merck & Co., Inc., and Bristol-Myers Squibb Company.

Scope of the Study

Market Segmentation:

By Type

• Diagnostics

• Computed Tomography Scan (CT Scan)
• Magnetic Resonance Imaging (MRI)
• Echocardiography
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography
• Others

• Therapeutics

• Tissue Plasminogen Activator
• Anticoagulant
• Antiplatelet
• Other Therapeutics Type

By Application                                                  

• Ischemic Stroke
• Hemorrhagic Stroke

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Companies Profiled

• ABBOTT Laboratories
• B. Braun Melsungen Ag
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Ge Healthcare
• Glaxosmithkline Plc
• Medtronic Plc
• Siemens Aktiengesellschaft
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

Chapter 1.    Market Scope & Methodology
1.1    Market Definition
1.2    Objectives
1.3    Market Scope
1.4    Segmentation
1.4.1    Europe Stroke Management Market, by Type
1.4.2    Europe Stroke Management Market, by Application
1.4.3    Europe Stroke Management Market, by Country
1.5    Methodology for the research
Chapter 2.    Market Overview
2.1    Introduction
2.1.1    Overview
2.1.2    Players Outlook for the Market
2.2    Key Factors Impacting the Market
2.2.1    Market Drivers
2.2.2    Market Restraints
Chapter 3.    Europe Stroke Management Market by Type
3.1.1    Europe Diagnostics Stroke Management Market by Country
3.1.1.1    Europe Stroke Management Market by Diagnostics Type
3.1.1.1.1    Europe Stroke Management Computed Tomography Scan (CT Scan) Market by Country
3.1.1.1.2    Europe Stroke Management Magnetic Resonance Imaging (MRI) Market by Country
3.1.1.1.3    Europe Stroke Management Echocardiography Market by Country
3.1.1.1.4    Europe Stroke Management Carotid Ultrasound Market by Country
3.1.1.1.5    Europe Stroke Management Cerebral Angiography Market by Country
3.1.1.1.6    Europe Stroke Management Electrocardiography Market by Country
3.1.1.1.7    Europe Other Diagnostics Type Stroke Management Market by Country
3.1.2    Europe Therapeutics Stroke Management Market by Country
3.1.2.1    Europe Stroke Management Market by Therapeutics Type
3.1.2.1.1    Europe Tissue Plasminogen Activator Stroke Management Market by Country
3.1.2.1.2    Europe Anticoagulant Stroke Management Market by Country
3.1.2.1.3    Europe Antiplatelet Stroke Management Market by Country
3.1.2.1.4    Europe Other Therapeutics Type Stroke Management Market by Country
Chapter 4.    Europe Stroke Management Market by Application
4.1.1    Europe Ischemic Stroke Management Market by Country
4.1.2    Europe Haemorrhagic Stroke Management Market by Country
Chapter 5.    Europe Stroke Management Market by Country
5.1    Germany Stroke Management Market
5.1.1    Germany Stroke Management Market by Type
5.1.1.1    Germany Stroke Management Market by Diagnostics Type
5.1.1.2    Germany Stroke Management Market by Therapeutics Type
5.1.2    Germany Stroke Management Market by Application
5.2    UK Stroke Management Market
5.2.1    UK Stroke Management Market by Type
5.2.1.1    UK Stroke Management Market by Diagnostics Type
5.2.1.2    UK Stroke Management Market by Therapeutics Type
5.2.2    UK Stroke Management Market by Application
5.3    France Stroke Management Market
5.3.1    France Stroke Management Market by Type
5.3.1.1    France Stroke Management Market by Diagnostics Type
5.3.1.2    France Stroke Management Market by Therapeutics Type
5.3.2    France Stroke Management Market by Application
5.4    Russia Stroke Management Market
5.4.1    Russia Stroke Management Market by Type
5.4.1.1    Russia Stroke Management Market by Diagnostics Type
5.4.1.2    Russia Stroke Management Market by Therapeutics Type
5.4.2    Russia Stroke Management Market by Application
5.5    Spain Stroke Management Market
5.5.1    Spain Stroke Management Market by Type
5.5.1.1    Spain Stroke Management Market by Diagnostics Type
5.5.1.2    Spain Stroke Management Market by Therapeutics Type
5.5.2    Spain Stroke Management Market by Application
5.6    Italy Stroke Management Market
5.6.1    Italy Stroke Management Market by Type
5.6.1.1    Italy Stroke Management Market by Diagnostics Type
5.6.1.2    Italy Stroke Management Market by Therapeutics Type
5.6.2    Italy Stroke Management Market by Application
5.7    Rest of Europe Stroke Management Market
5.7.1    Rest of Europe Stroke Management Market by Type
5.7.1.1    Rest of Europe Stroke Management Market by Diagnostics Type
5.7.1.2    Rest of Europe Stroke Management Market by Therapeutics Type
5.7.2    Rest of Europe Stroke Management Market by Application
Chapter 6.    Company Profiles
6.1    B. Braun Melsungen AG.
6.1.1    Company Overview
6.1.2    Financial Analysis
6.1.3    Segmental Analysis
6.1.4    Research & Development Expense
6.2    ABBOTT
6.2.1    Company Overview
6.2.2    Financial Analysis
6.2.3    Regional & Segmental Analysis
6.2.4    Research & Development Expense
6.3    Cardinal Health
6.3.1    Company Overview
6.3.2    Financial Analysis
6.3.3    Segmental Analysis
6.4    Medtronic Plc.
6.4.1    Company Overview
6.4.2    Financial Analysis
6.4.3    Segmental and Regional Analysis
6.4.4    Research & Development Expense
6.5    General Electric (GE) (GE Healthcare)
6.5.1    Company Overview
6.5.2    Financial Analysis
6.5.3    Segmental and Regional Analysis
6.5.4    Research & Development Expense
6.6    Siemens Healthineers
6.6.1    Company Overview
6.6.2    Financial Analysis
6.6.3    Segmental Analysis
6.6.4    Research & Development Expense
6.7    Bristol-Myers Squibb
6.7.1    Company Overview
6.7.2    Financial Analysis
6.7.3    Regional Analysis
6.7.4    Research & Development Expense
6.8    Merck & Company Inc.
6.8.1    Company Overview
6.8.2    Financial Analysis
6.8.3    Segmental Analysis
6.8.4    Research & Development Expense
6.9    Glaxosmithkline Plc.
6.9.1    Company Overview
6.9.2    Financial Analysis
6.9.3    Segmental Analysis
6.9.4    Research & Development Expense

TABLE 1    EUROPE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 2    EUROPE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 3    EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 4    EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 5    EUROPE DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 6    EUROPE DIAGNOSTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 7    EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 8    EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 9    EUROPE STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 10    EUROPE STROKE MANAGEMENT COMPUTED TOMOGRAPHY SCAN (CT SCAN) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 11    EUROPE STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 12    EUROPE STROKE MANAGEMENT MAGNETIC RESONANCE IMAGING (MRI) MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 13    EUROPE STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 14    EUROPE STROKE MANAGEMENT ECHOCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 15    EUROPE STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 16    EUROPE STROKE MANAGEMENT CAROTID ULTRASOUND MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 17    EUROPE STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 18    EUROPE STROKE MANAGEMENT CEREBRAL ANGIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 19    EUROPE STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 20    EUROPE STROKE MANAGEMENT ELECTROCARDIOGRAPHY MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 21    EUROPE OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 22    EUROPE OTHER DIAGNOSTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 23    EUROPE THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 24    EUROPE THERAPEUTICS STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 25    EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 26    EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 27    EUROPE TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 28    EUROPE TISSUE PLASMINOGEN ACTIVATOR STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 29    EUROPE ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 30    EUROPE ANTICOAGULANT STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 31    EUROPE ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 32    EUROPE ANTIPLATELET STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 33    EUROPE OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 34    EUROPE OTHER THERAPEUTICS TYPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 35    EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 36    EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 37    EUROPE ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 38    EUROPE ISCHEMIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 39    EUROPE HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 40    EUROPE HAEMORRHAGIC STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 41    EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2014 - 2017, USD MILLION
TABLE 42    EUROPE STROKE MANAGEMENT MARKET BY COUNTRY, 2018 - 2024, USD MILLION
TABLE 43    GERMANY STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 44    GERMANY STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 45    GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 46    GERMANY STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 47    GERMANY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 48    GERMANY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 49    GERMANY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 50    GERMANY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 51    GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 52    GERMANY STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 53    UK STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 54    UK STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 55    UK STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 56    UK STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 57    UK STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 58    UK STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 59    UK STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 60    UK STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 61    UK STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 62    UK STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 63    FRANCE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 64    FRANCE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 65    FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 66    FRANCE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 67    FRANCE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 68    FRANCE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 69    FRANCE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 70    FRANCE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 71    FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 72    FRANCE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 73    RUSSIA STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 74    RUSSIA STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 75    RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 76    RUSSIA STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 77    RUSSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 78    RUSSIA STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 79    RUSSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 80    RUSSIA STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 81    RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 82    RUSSIA STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 83    SPAIN STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 84    SPAIN STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 85    SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 86    SPAIN STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 87    SPAIN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 88    SPAIN STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 89    SPAIN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 90    SPAIN STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 91    SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 92    SPAIN STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 93    ITALY STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 94    ITALY STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 95    ITALY STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 96    ITALY STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 97    ITALY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 98    ITALY STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 99    ITALY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 100    ITALY STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 101    ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 102    ITALY STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 103    REST OF EUROPE STROKE MANAGEMENT MARKET, 2014 - 2017, USD MILLION
TABLE 104    REST OF EUROPE STROKE MANAGEMENT MARKET, 2018 - 2024, USD MILLION
TABLE 105    REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2014 - 2017, USD MILLION
TABLE 106    REST OF EUROPE STROKE MANAGEMENT MARKET BY TYPE, 2018 - 2024, USD MILLION
TABLE 107    REST OF EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2014 - 2017, USD MILLION
TABLE 108    REST OF EUROPE STROKE MANAGEMENT MARKET BY DIAGNOSTICS TYPE, 2018 - 2024, USD MILLION
TABLE 109    REST OF EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2014 - 2017, USD MILLION
TABLE 110    REST OF EUROPE STROKE MANAGEMENT MARKET BY THERAPEUTICS TYPE, 2018 - 2024, USD MILLION
TABLE 111    REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2014 - 2017, USD MILLION
TABLE 112    REST OF EUROPE STROKE MANAGEMENT MARKET BY APPLICATION, 2018 - 2024, USD MILLION
TABLE 113    KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 114    KEY INFORMATION – ABBOTT
TABLE 115    KEY INFORMATION – CARDINAL HEALTH
TABLE 116    BUSINESS SEGMENT – CARDINAL HEALTH
TABLE 117    KEY INFORMATION – MEDTRONIC PLC
TABLE 118    KEY INFORMATION – MEDTRONIC
TABLE 119    KEY INFORMATION – GENERAL ELECTRIC (GE)
TABLE 120    KEY INFORMATION - SIEMENS HEALTHINEERS
TABLE 121    KEY INFORMATION - BRISTOL-MYERS SQUIBB
TABLE 122    KEY INFORMATION - MERCK & COMPANY INC.
TABLE 123    KEY INFORMATION - GLAXOSMITHKLINE PLC.